Yet UK and European drug regulators specify access to 2 adrenaline devices at all times Giving ‘spare’ devices to all schools would be safer and save local health bodies £millions Less than half of schoolchildren in England who are at risk of a serious and potentially life-threatening allergic reaction (anaphylaxis) ...
Replication in other populations and settings needed to confirm and extend these observations, say researchers Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group of diabetes drugs called ...
While it likely increases the risk of serious side effects, including heart disease Potential harms probably outweigh benefits, and use should be minimised, say researchers The strong opioid painkiller, tramadol, is not that effective at easing chronic pain for which it’s widely prescribed, finds a pooled data analysis of the ...
Over 200,000 patients may be eligible for treatment in the first three years, but some commissioners are already considering tighter prescribing criteria or rationing Figures confirm the fear that the roll out is not fit for purpose, says expert Less than half of England has access to tirzepatide (Mounjaro) through ...
Higher volume prescribers more likely to receive payments; and recipients more likely to prescribe that company’s drugs, especially if payments were larger, sustained, and recent Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to ...
Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...
Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks ...
Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...
Findings should help inform clinical practice and the debate on ADHD drug treatment Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviours, substance misuse, transport accidents, and criminality, finds a study published by The BMJ today. The researchers say this ...
Findings suggest future guidelines prioritise drugs with dual blood glucose and neuroprotective effects GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, published in ...
Copyright © 2025 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
